Article Information
History
- March 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rishi R. Goel1,2,*,
- Sokratis A. Apostolidis1,2,3,*,
- Mark M. Painter1,2,*,
- Divij Mathew1,2,*,
- Ajinkya Pattekar2,
- Oliva Kuthuru1,
- Sigrid Gouma4,
- Leticia Kuri-Cervantes1,4,
- Wenzhao Meng1,5,
- Sharon Adamski2,
- Amy E. Baxter1,
- Josephine R. Giles1,6,7,
- Madison E. Weirick4,
- Christopher M. McAllister4,
- Amanda Hicks2,
- Scott Korte2,
- Jeanette Dougherty1,
- Sherea Long1,
- Kurt D’Andrea2,
- Jacob T. Hamilton2,
- Eline T Luning Prak1,5,
- Michael R. Betts1,4,
- Paul Bates4,
- Scott E. Hensley4,
- Allison R. Greenplate1,2 and
- E. John Wherry1,2,6,7,†
- 1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 3Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 4Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 5Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 6Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 7Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- ↵†corresponding author: wherry{at}pennmedicine.upenn.edu
↵* authors contributed equally